|
2023
|
Invention
|
Methods and compositions for self-regulated release of active pharmaceutical ingredient.
An abus... |
|
|
Invention
|
Methods and compositions for interfering with extraction or conversion of a drug susceptible to a... |
|
2022
|
Invention
|
Methods and compositions for self-regulated release of active pharmaceutical ingredients.
An abu... |
|
2021
|
Invention
|
Methods and compositions for self-regulated release of active pharmaceutical ingredient. An abuse... |
|
2020
|
Invention
|
Abuse deterrent compositions and methods of making same.
This invention relates a therapeutic ph... |
|
2018
|
Invention
|
Methods and compositions for self-regulated release of active pharmaceutical ingredients. An abus... |
|
|
Invention
|
Methods and compositions for self-regulated release of active pharmaceuticals ingredients. An abu... |
|
2017
|
Invention
|
Methods and compositions for deterring abuse. Effective methods and compositions to deter abuse o... |
|
2016
|
Invention
|
Methods and compositions for regulating conversion of a prodrug to an active pharmaceutical ingre... |
|
2014
|
G/S
|
Pharmaceutical preparations, namely, immediate-release oxycodone hydrochloride for pain relief in... |
|
|
Invention
|
Abuse deterrent compositions and methods of making same. This invention relates a therapeutic pha... |
|
|
Invention
|
Methods and compositions for deterring abuse. A therapeutic composition comprising: a methampheta... |
|
|
Invention
|
Methods and compositions for deterring abuse.
A therapeutic composition comprising: a methamphet... |
|
2013
|
Invention
|
Self-regulated release of active pharmaceutical ingredient. An abuse deterrent pharmaceutical com... |
|
|
Invention
|
Stabilization of one-pot methamphetamine synthesis systems.
Methods and compositions for stabili... |
|
|
Invention
|
Stabilization of one-pot methamphetamine synthesis systems. Methods and compositions for stabiliz... |
|
2012
|
Invention
|
Methods and compositions for deterring abuse of orally administered pharmaceutical products.
Thi... |
|
2011
|
Invention
|
Extended release opioid abuse deterrent compositions and methods of making same. This invention r... |
|
|
Invention
|
Optimized niacin compositions in pharmaceutical products.
The present invention includes composi... |
|
|
Invention
|
Optimized niacin compositions in pharmaceutical products. The present invention includes composit... |
|
|
G/S
|
Pharmaceutical preparations, namely, oral medications containing pseudoephedrine hydrochloride fo... |
|
2010
|
Invention
|
Pharmaceutical compositions for deterring misuse, abuse, and diversion.
Pharmaceutical compositi... |
|
|
Invention
|
Pharmaceutical compositions for deterring misuse, abuse, and diversion. Pharmaceutical compositio... |
|
2008
|
G/S
|
Prescription pharmaceuticals, namely, an analgesic for human use |
|
|
Invention
|
Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms there... |
|
|
G/S
|
Pharmaceutical research and development services. |
|
2007
|
Invention
|
Methods and compositions for deterring abuse of orally administered pharmaceutical products. This... |
|
|
Invention
|
Methods and compositions for deterring abuse of opioid containing dosage forms. This invention re... |
|
2005
|
Invention
|
Production of opioid analgesics. The present invention includes a process for the manufacture of ... |
|
2004
|
G/S
|
Pharmaceutical research and development services |
|
|
G/S
|
Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possi... |
